ARCHIVES

Drugs and Targets: Blincyto granted accelerated approval in R/R ALL

This article is from The Cancer Letter archive.

Vol. 40 No. 45 | December 5, 2014

Download PDF Visit The Full Archive

Related Articles

Schmidt’s Doubts Threaten Control Saturation Program

August 22, 1975

Proteomics Used To Find Predictor Of Response In FAP

April 30, 2004

Suit Against Craig Thompson Settled As Company He Co-Founded Licenses “Newly Identified” Discoveries From UPenn

September 14, 2012

Task Force: No Routine Mammograms Until 50

November 20, 2009

Radiotherapy In Combination With Zometa Provide Pain Control For Advanced Myeloma

February 27, 2004

Children’s Oncology Group Study Shows Improved Care For Childhood Brain Tumors

October 31, 2008